SANUWAVE Health, Inc. (SNWV) 8-K Current Report: March 13, 2026
Filed: March 13, 2026
Health Care
Surgical & Medical Instruments & ApparatusSANUWAVE Health, Inc. (SNWV) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 4.02: Non-Reliance on Previously Issued Financial Statements
SANUWAVE Health, Inc. 8-K Mar 13, 2026 Event Analysis
Item 4.02 · Non-Reliance on Previously Issued Financial Statements
- • Audit committee declared all financial statements from Q1 2024 through Q3 2025 unreliable — full restatement required across 6 quarterly periods plus FY2024 annual
- • Root cause: undisclosed historical state sales & use tax liability discovered via third-party nexus study — indicates prior compliance failure
- • Balance sheet impact: liabilities to increase $4.9M–$5.2M; expense hit $1.6M–$1.8M for FY2024 and $1.7M–$1.9M for FY2025 (taxes, interest, penalties)
- • Management evaluating additional material weaknesses in internal controls — findings to be disclosed in 2025 Form 10-K
- • Restatement scope spanning ~2 years signals systemic oversight failure; investors should watch for further control deficiencies and potential SEC scrutiny
Get deeper insights on SANUWAVE Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.